Biotech · Private company
Rain Oncology Inc
Track this companyFree. Adds Rain Oncology Inc to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- RAIN-32Phase 3 · Dedifferentiated LiposarcomaClinicalTrials.gov · fetched Nov 12, 2026
- TrabectedinPhase 3 · Dedifferentiated LiposarcomaClinicalTrials.gov · fetched Nov 12, 2026
- RAIN-32Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- tarloxotinib bromidePhase 2 · NSCLC, Stage IVClinicalTrials.gov · fetched Nov 12, 2026
- TH-4000 (Tarloxotinib)Phase 2 · Metastatic Head-and-neck Squamous-cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TH-4000 (Tarloxotinib)Phase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Tarlox and Sotorasib in Patients With KRAS G12C MutationsPHASE1_PHASE2 · TERMINATED · started Mar 7, 2022ClinicalTrials.gov NCT05313009 · fetched Nov 12, 2026
- Milademetan in Advanced/Metastatic Solid TumorsPHASE2 · TERMINATED · started Nov 1, 2021ClinicalTrials.gov NCT05012397 · fetched Nov 12, 2026
- Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated LiposarcomaPHASE3 · TERMINATED · started Jul 14, 2021ClinicalTrials.gov NCT04979442 · fetched Nov 12, 2026
- Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene FusionsPHASE2 · TERMINATED · started Mar 13, 2019ClinicalTrials.gov NCT03805841 · fetched Nov 12, 2026
- Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or SkinPHASE2 · TERMINATED · started Aug 1, 2015ClinicalTrials.gov NCT02449681 · fetched Nov 12, 2026
- Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) PatientsPHASE2 · TERMINATED · started Jun 1, 2015ClinicalTrials.gov NCT02454842 · fetched Nov 12, 2026